158 related articles for article (PubMed ID: 22341582)
1. The use of silica coated MnO nanoparticles to control MRI relaxivity in response to specific physiological changes.
Lee YC; Chen DY; Dodd SJ; Bouraoud N; Koretsky AP; Krishnan KM
Biomaterials; 2012 May; 33(13):3560-7. PubMed ID: 22341582
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
3. Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.
Martinez de la Torre C; Grossman JH; Bobko AA; Bennewitz MF
PLoS One; 2020; 15(9):e0239034. PubMed ID: 32946514
[TBL] [Abstract][Full Text] [Related]
4. pH-Activatable MnO-Based Fluorescence and Magnetic Resonance Bimodal Nanoprobe for Cancer Imaging.
Hsu BY; Ng M; Tan A; Connell J; Roberts T; Lythgoe M; Zhang Y; Wong SY; Bhakoo K; Seifalian AM; Li X; Wang J
Adv Healthc Mater; 2016 Mar; 5(6):721-9. PubMed ID: 26895111
[TBL] [Abstract][Full Text] [Related]
5. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
6. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
7. Tailored biological retention and efficient clearance of pegylated ultra-small MnO nanoparticles as positive MRI contrast agents for molecular imaging.
Chevallier P; Walter A; Garofalo A; Veksler I; Lagueux J; Bégin-Colin S; Felder-Flesch D; Fortin MA
J Mater Chem B; 2014 Apr; 2(13):1779-1790. PubMed ID: 32261515
[TBL] [Abstract][Full Text] [Related]
8. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
9. Manganese-impregnated mesoporous silica nanoparticles for signal enhancement in MRI cell labelling studies.
Guillet-Nicolas R; Laprise-Pelletier M; Nair MM; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Kleitz F; Fortin MA
Nanoscale; 2013 Dec; 5(23):11499-511. PubMed ID: 24178890
[TBL] [Abstract][Full Text] [Related]
10. Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive
Wei R; Liu K; Zhang K; Fan Y; Lin H; Gao J
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3784-3791. PubMed ID: 35019261
[TBL] [Abstract][Full Text] [Related]
11. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.
Zheng Y; Zhang H; Hu Y; Bai L; Xue J
Int J Nanomedicine; 2018; 13():6177-6188. PubMed ID: 30323598
[TBL] [Abstract][Full Text] [Related]
12. A new and facile method to prepare uniform hollow MnO/functionalized mSiO₂ core/shell nanocomposites.
Peng YK; Lai CW; Liu CL; Chen HC; Hsiao YH; Liu WL; Tang KC; Chi Y; Hsiao JK; Lim KE; Liao HE; Shyue JJ; Chou PT
ACS Nano; 2011 May; 5(5):4177-87. PubMed ID: 21548648
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
14. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI.
Bennewitz MF; Lobo TL; Nkansah MK; Ulas G; Brudvig GW; Shapiro EM
ACS Nano; 2011 May; 5(5):3438-46. PubMed ID: 21495676
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble and biocompatible MnO@PVP nanoparticles for MR imaging in vitro and in vivo.
Hu X; Ji Y; Wang M; Miao F; Ma H; Shen H; Jia N
J Biomed Nanotechnol; 2013 Jun; 9(6):976-84. PubMed ID: 23858961
[TBL] [Abstract][Full Text] [Related]
16. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
17. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
[TBL] [Abstract][Full Text] [Related]
18. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma.
Lai J; Wang T; Wang H; Shi F; Gu W; Ye L
Mikrochim Acta; 2018 Apr; 185(4):244. PubMed ID: 29610993
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.
Baek MJ; Park JY; Xu W; Kattel K; Kim HG; Lee EJ; Patel AK; Lee JJ; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
ACS Appl Mater Interfaces; 2010 Oct; 2(10):2949-55. PubMed ID: 20929249
[TBL] [Abstract][Full Text] [Related]
20. The effect of manganese nanoparticles on performance, redox reactions and epigenetic changes in turkey tissues.
Ognik K; Kozłowski K; Stępniowska A; Szlązak R; Tutaj K; Zduńczyk Z; Jankowski J
Animal; 2019 Jun; 13(6):1137-1144. PubMed ID: 30378527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
